The AHA today submitted comments on the Food and Drug Administration’s Medical Device Safety Action Plan. Released in April, the plan outlines new pre- and post-market authorities, guidance and an expert board under consideration by the agency to improve device security and how device makers disclose and respond to vulnerabilities. “The AHA supports these steps, which would make important improvements to the FDA’s oversight of medical device manufacturers with respect to the security of their products,” the association said. “We urge the FDA to move as quickly as possible to implement them and make public its timeline for the benefit of all stakeholders.” With respect to guidance, AHA said device manufacturers “must be held accountable to proactively minimize risk by building security into products by design, providing security tools to their end-users and updating and patching devices as new intelligence and threats emerge.” The association also recommended including health care providers as a partner on an expert board being contemplated by the agency.

Related News Articles

Headline
By integrating behavioral health into physical care and tapping into community partnerships, hospitals and health systems can develop culturally competent…
Headline
Yale New Haven Health will receive the 2021 AHA Quest for Quality Prize this week at AHA’s annual Leadership Summit for its deep commitment to improving the…
Chairperson's File
AHA’s Institute for Diversity and Health Equity has been working for more than 25 years to advance health equity, diversity and inclusion by supporting…
Blog
There’s no turning away from the physical and emotional suffering caused by the COVID-19 pandemic. We’ve experienced every type of upheaval — in some cases…
News
Reps. Peter Welch, D-Vt., Suzan DelBene, D-Wash., Darin LaHood, R-Ill., and Brad Wenstrup, R-Ohio, yesterday reintroduced the Value in Health Care Act, AHA-…
News
The Centers for Medicare & Medicaid Services today advised clinicians in the Medicare Quality Payment Program who earned but did not receive an alternative…